However, except for HSD11B1 and SH2D2A in infiltrating ductal carcinoma, other MDGs did not have statistically significant clinical outcome (Figure S2F-G), possibly due to small sample size. The gene discussed is HSD11B1; the disease is invasive ductal breast carcinoma.